Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma Eligible for Lymph Node Sentinel Biopsy (CORRESPOND): an Observational Prospective Study.

The article focuses on a study investigating the use of gene expression profiles and ctDNA for risk stratification in melanoma patients eligible for lymph node sentinel biopsy. Topics include assessing MerlinTM and ctDNA in predicting nodal status, evaluating their impact on clinical models, and the study's goal of improving risk stratification for adjuvant therapy.